Mirk/Dyrk1B Mediates Survival During the Differentiation of C2C12 Myoblasts

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2005 Apr 27

PMID 15851482

Citations 48

Authors

Stephen E Mercer

Daina Z Ewton

Xiaobing Deng

Seunghwan Lim

Thomas R Mazur

Eileen Friedman

Affiliations

Soon will be listed here.

Abstract

The kinase Mirk/dyrk1B is essential for the differentiation of C2C12 myoblasts. Mirk reinforces the G0/G1 arrest state in which differentiation occurs by directly phosphorylating and stabilizing p27(Kip1) and destabilizing cyclin D1. We now demonstrate that Mirk is anti-apoptotic in myoblasts. Knockdown of endogenous Mirk by RNA interference activated caspase 3 and decreased myoblast survival by 75%, whereas transient overexpression of Mirk increased cell survival. Mirk exerts its anti-apoptotic effects during muscle differentiation at least in part through effects on the cell cycle inhibitor and pro-survival molecule p21(Cip1). Overexpression and RNA interference experiments demonstrated that Mirk phosphorylates p21 within its nuclear localization domain at Ser-153 causing a portion of the typically nuclear p21 to localize in the cytoplasm. Phosphomimetic GFP-p21-S153D was pancellular in both cycling C2C12 myoblasts and NIH3T3 cells. Endogenous Mirk in myotubes and overexpressed Mirk in NIH3T3 cells were able to cause the pancellular localization of wild-type GFP-p21 but not the nonphosphorylatable mutant GFP-p21-S153A. Translocation to the cytoplasm enables p21 to block apoptosis through inhibitory interaction with pro-apoptotic molecules. Phosphomimetic p21-S153D was more effective than wild-type p21 in blocking the activation of caspase 3. Transient expression of p21-S153D also increased myoblast viability in colony forming assays, whereas the p21-S153A mutant had no effect. This Mirk-dependent change in p21 intracellular localization is a natural part of myoblast differentiation. Endogenous p21 localized exclusively to the nuclei of proliferating myoblasts but was also found in the cytoplasm of post-mitotic multinucleated myotubes and adult human skeletal myofibers.

Citing Articles

A safe haven for cancer cells: tumor plus stroma control by DYRK1B.

Ems M, Brichkina A, Lauth M Oncogene. 2025; 44(6):341-347.

PMID: 39863750 PMC: 11790486. DOI: 10.1038/s41388-025-03275-6.

Hepatic Dyrk1b impairs systemic glucose homeostasis by modulating Wbp2 expression in a kinase activity-dependent manner.

Li L, Zou Y, Shen C, Chen N, Tong M, Liu R Heliyon. 2024; 10(17):e36726.

PMID: 39296215 PMC: 11407929. DOI: 10.1016/j.heliyon.2024.e36726.

-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents.

Mostafa N, Chen P, Darwish S, Su Y, Shiao M, Piazza G Cancers (Basel). 2024; 16(11).

PMID: 38893153 PMC: 11171218. DOI: 10.3390/cancers16112033.

Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy.

Kokkorakis N, Zouridakis M, Gaitanou M Pharmaceutics. 2024; 16(4).

PMID: 38675189 PMC: 11053710. DOI: 10.3390/pharmaceutics16040528.

Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway.

Kokkorakis N, Douka K, Nalmpanti A, Politis P, Zagoraiou L, Matsas R Cell Mol Life Sci. 2024; 81(1):70.

PMID: 38294527 PMC: 10830675. DOI: 10.1007/s00018-023-05097-9.

References

Xia W, Chen J, Zhou X, Sun P, Lee D, Liao Y . Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin Cancer Res. 2004; 10(11):3815-24. DOI: 10.1158/1078-0432.CCR-03-0527. View

Diamant S, Bukau B, Goloubinoff P . Size-dependent disaggregation of stable protein aggregates by the DnaK chaperone machinery. J Biol Chem. 2000; 275(28):21107-13. DOI: 10.1074/jbc.M001293200. View

Wang J, Walsh K . Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 1996; 273(5273):359-61. PMC: 3641673. DOI: 10.1126/science.273.5273.359. View

Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor F, Joost H . Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem. 1998; 273(40):25893-902. DOI: 10.1074/jbc.273.40.25893. View

Zhang P, Wong C, Liu D, Finegold M, Harper J, Elledge S . p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev. 1999; 13(2):213-24. PMC: 316389. DOI: 10.1101/gad.13.2.213. View

Kentrup H, Becker W, Heukelbach J, Wilmes A, Schurmann A, Huppertz C . Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem. 1996; 271(7):3488-95. DOI: 10.1074/jbc.271.7.3488. View

Waga S, Hannon G, Beach D, Stillman B . The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 1994; 369(6481):574-8. DOI: 10.1038/369574a0. View

Alt J, Gladden A, Diehl J . p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem. 2001; 277(10):8517-23. DOI: 10.1074/jbc.M108867200. View

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

10.

Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M . Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol. 2002; 158(2):321-9. PMC: 2173114. DOI: 10.1083/jcb.200202071. View

11.

Gonzalez I, Tripathi G, Carter E, Cobb L, Salih D, Lovett F . Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol. 2004; 24(9):3607-22. PMC: 387733. DOI: 10.1128/MCB.24.9.3607-3622.2004. View

12.

Dotto G . p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim Biophys Acta. 2000; 1471(1):M43-56. DOI: 10.1016/s0304-419x(00)00019-6. View

13.

Taminato A, Bagattini R, Gorjao R, Chen G, Kuspa A, Souza G . Role for YakA, cAMP, and protein kinase A in regulation of stress responses of Dictyostelium discoideum cells. Mol Biol Cell. 2002; 13(7):2266-75. PMC: 117311. DOI: 10.1091/mbc.01-11-0555. View

14.

Xiong Y, Zhang H, Beach D . D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 1992; 71(3):505-14. DOI: 10.1016/0092-8674(92)90518-h. View

15.

Yang S, Galanis A, Sharrocks A . Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol Cell Biol. 1999; 19(6):4028-38. PMC: 104362. DOI: 10.1128/MCB.19.6.4028. View

16.

Ostrovsky O, Bengal E . The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein. J Biol Chem. 2003; 278(23):21221-31. DOI: 10.1074/jbc.M211357200. View

17.

Rossig L, Badorff C, Holzmann Y, Zeiher A, Dimmeler S . Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem. 2002; 277(12):9684-9. DOI: 10.1074/jbc.M106157200. View

18.

Sherr C, Roberts J . Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995; 9(10):1149-63. DOI: 10.1101/gad.9.10.1149. View

19.

Lim S, Zou Y, Friedman E . The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase. J Biol Chem. 2002; 277(51):49438-45. DOI: 10.1074/jbc.M206840200. View

20.

Blagosklonny M . Are p27 and p21 cytoplasmic oncoproteins?. Cell Cycle. 2003; 1(6):391-3. DOI: 10.4161/cc.1.6.262. View